Blackhouse G - Search Results

1

Patient outcomes after anti TNF-alpha drugs for Crohn's disease.

Assasi N, Blackhouse G, Xie F, Marshall JK, Irvine EJ, Gaebel K, Robertson D, Campbell K, Hopkins R, Goeree R. Assasi N, et al. Among authors: blackhouse g. Expert Rev Pharmacoecon Outcomes Res. 2010 Apr;10(2):163-75. doi: 10.1586/erp.10.13. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20384563 Review.

2

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

O'Brien BJ, Goeree R, Hux M, Iskedjian M, Blackhouse G, Gagnon M, Gauthier S. O'Brien BJ, et al. Among authors: blackhouse g. J Am Geriatr Soc. 1999 May;47(5):570-8. doi: 10.1111/j.1532-5415.1999.tb02572.x. J Am Geriatr Soc. 1999. PMID: 10323651

3

The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia.

Goeree R, O'Brien BJ, Blackhouse G, Agro K, Goering P. Goeree R, et al. Among authors: blackhouse g. Can J Psychiatry. 1999 Jun;44(5):455-63. doi: 10.1177/070674379904400505. Can J Psychiatry. 1999. PMID: 10389606

4

The economic burden of schizophrenia in Canada.

Goeree R, O'Brien BJ, Goering P, Blackhouse G, Agro K, Rhodes A, Watson J. Goeree R, et al. Among authors: blackhouse g. Can J Psychiatry. 1999 Jun;44(5):464-72. doi: 10.1177/070674379904400506. Can J Psychiatry. 1999. PMID: 10389607

5

Hospital selection for unit cost estimates in multicentre economic evaluations. Does the choice of hospitals make a difference?

Goeree R, Gafni A, Hannah M, Myhr T, Blackhouse G. Goeree R, et al. Among authors: blackhouse g. Pharmacoeconomics. 1999 Jun;15(6):561-72. doi: 10.2165/00019053-199915060-00004. Pharmacoeconomics. 1999. PMID: 10538329

6

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M. O'Brien B, et al. Among authors: blackhouse g. Arch Intern Med. 1999 Oct 25;159(19):2298-304. doi: 10.1001/archinte.159.19.2298. Arch Intern Med. 1999. PMID: 10547169 Clinical Trial.

7

Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?

O'Brien BJ, Willan A, Blackhouse G, Goeree R, Cohen M, Goodman S. O'Brien BJ, et al. Among authors: blackhouse g. Am Heart J. 2000 Mar;139(3):423-9. doi: 10.1016/s0002-8703(00)90085-1. Am Heart J. 2000. PMID: 10689256 Clinical Trial.

8

Economic evaluation of long-term management strategies for erosive oesophagitis.

Goeree R, O'Brien B, Hunt R, Blackhouse G, Willan A, Watson J. Goeree R, et al. Among authors: blackhouse g. Pharmacoeconomics. 1999 Dec;16(6):679-97. doi: 10.2165/00019053-199916060-00007. Pharmacoeconomics. 1999. PMID: 10724795

9

Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).

O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M. O'Brien BJ, et al. Among authors: blackhouse g. Circulation. 2001 Mar 13;103(10):1416-21. doi: 10.1161/01.cir.103.10.1416. Circulation. 2001. PMID: 11245646 Clinical Trial.

10

Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication.

Agro K, Blackhouse G, Goeree R, Willan AR, Huang JQ, Hunt RH, O'Brien BJ. Agro K, et al. Among authors: blackhouse g. Pharmacoeconomics. 2001;19(8):831-43. doi: 10.2165/00019053-200119080-00005. Pharmacoeconomics. 2001. PMID: 11596835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page